Sharma Namrata, Prakash Gaurav, Sinha Rajesh, Tandon Radhika, Titiyal Jeewan S, Vajpayee Rasik B
Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Cornea. 2008 Jan;27(1):44-9. doi: 10.1097/ICO.0b013e318157a111.
To analyze the indications and outcomes of phototherapeutic keratectomy (PTK) in the developing world.
In this retrospective study, the records of 203 consecutive eyes of 191 patients who had undergone PTK at a tertiary eye care center were evaluated. The parameters assessed were indications of PTK, demographic features, best spectacle-corrected visual acuity (BSCVA), and pachymetry. PTK was done by using a 193-nm Ar-F Excimer laser (Chiron Technolas Keracor 217 C) in a 6-mm optic zone. Patients were followed up for 6 months.
The most common indication of PTK was symptomatic bullous keratopathy (103 eyes). The patients were divided into 2 groups: those with bullous keratopathy (PTK BK) and those with superficial corneal pathologies (PTK CS). In the PTK CS group, the most common indications were Salzmann nodular degeneration (n = 27) and spheroidal degeneration (n = 22). BSCVA improved from 20/222 (0.09) to 20/86 (0.23) in the PTK CS group and 20/384 (0.05) to 20/202 (0.09) in the PTK BK group (P < 0.0001 in both groups). There was a significant decrease in the number of patients with severe symptoms in the PTK-BK (P < 0.0001) and PTK-CS (P = 0.017) groups. The change in BSCVA was significantly related to both pre-PTK BSCVA and pachymetry in PTK-BK.
PTK is an efficacious treatment modality for symptomatic relief and visual gain in cases with superficial corneal involvement and bullous keratopathy.
分析在发展中国家光治疗性角膜切削术(PTK)的适应证及治疗效果。
在这项回顾性研究中,对一家三级眼科护理中心连续191例患者的203只接受PTK治疗的眼睛的记录进行了评估。评估的参数包括PTK的适应证、人口统计学特征、最佳矫正视力(BSCVA)和角膜测厚。PTK使用193纳米的氩氟准分子激光(Chiron Technolas Keracor 217 C)在6毫米的光学区进行。患者随访6个月。
PTK最常见的适应证是症状性大疱性角膜病变(103只眼)。患者分为两组:大疱性角膜病变组(PTK BK)和浅表角膜病变组(PTK CS)。在PTK CS组中,最常见的适应证是萨尔茨曼结节状变性(n = 27)和球形变性(n = 22)。PTK CS组的BSCVA从20/222(0.09)提高到20/86(0.23),PTK BK组从20/384(0.05)提高到20/202(0.09)(两组P均<0.0001)。PTK - BK组(P < 0.0001)和PTK - CS组(P = 0.017)中严重症状患者的数量显著减少。PTK - BK组中BSCVA的变化与PTK术前的BSCVA和角膜厚度均显著相关。
PTK是一种有效的治疗方式,可缓解浅表角膜受累和大疱性角膜病变患者的症状并提高视力。